Sintx Technologies (SINT) Capital Expenditures Growth (1y) (2014 - 2026)
Sintx Technologies (SINT) Capital Expenditures Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.82 Bn | 176.53 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.59 Bn | 67.14 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.11 Bn | 25.82 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.28 Bn | 21.15 Bn | 2.07 Bn | -47.73% |
| 10 | Sintx Technologies | 5.70 Mn | 3.81 Mn | 144,000.00 | -88.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88.14% |
| Dec 31, 2025 | -71.23% |
| Sep 30, 2025 | 663.64% |
| Mar 31, 2025 | -66.09% |
| Dec 31, 2024 | 97.30% |
| Sep 30, 2024 | -90.98% |
| Jun 30, 2024 | 266.33% |
| Mar 31, 2024 | -26.27% |
| Dec 31, 2023 | -75.00% |
| Sep 30, 2023 | -76.13% |
| Jun 30, 2023 | -73.37% |
| Mar 31, 2023 | 2.61% |
| Dec 31, 2022 | -44.57% |
| Sep 30, 2022 | -80.22% |
| Jun 30, 2022 | -15.40% |
| Mar 31, 2022 | 20.42% |
| Dec 31, 2021 | 154.29% |
| Sep 30, 2021 | 3,439.73% |
| Jun 30, 2021 | 676.79% |
| Mar 31, 2021 | 809.52% |